Cell‐by‐cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression

Abstract The androgen receptor (AR) plays a crucial role in the development and homeostasis of the prostate and is a key therapeutic target in prostate cancer (PCa). The gold standard therapy for advanced PCa is androgen deprivation therapy (ADT), which targets androgen production and AR signaling....

ver descrição completa

Detalhes bibliográficos

Principais autores:	Seta Derderian, Tarik Benidir, Eleonora Scarlata, Turki Altaylouni, Lucie Hamel, Fatima Zahra Zouanat, Fadi Brimo, Armen Aprikian, Simone Chevalier
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2023-07-01
coleção:	The Journal of Pathology: Clinical Research
Assuntos:	prostate cancer castration resistant prostate cancer metastasis androgen deprivation therapy androgen receptor AR
Acesso em linha:	https://doi.org/10.1002/cjp2.319
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!